Table 4.
30 day outcome | Absolute risk reduction* (%, 95% CI) | ||
---|---|---|---|
All admissions | Inpatient only | HEDIS regulatory definition only† | |
Non-elective readmission | −2.7 (−3.2 to −2.2) | −2.9 (−3.4 to −2.3) | −2.5 (−3.1 to −1.9) |
Post-discharge mortality | −0.7 (−1.4 to −0.0) | −0.9 (−1.7 to −0.1) | NA† |
Out-of-hospital mortality | −0.4 (−1.1 to 0.2) | −0.5 (−1.2 to 0.2) | NA† |
HEDIS=Healthcare Effectiveness Data and Information Set; NA=not applicable.
Regression discontinuity design fits the estimates only near 25% risk threshold used to assign the Transitions Program intervention; hence, these local average treatment effect (LATE) estimates do not generalize to higher or lower risk levels.
Estimate for LATE.
Excludes patients with <30 days of follow-up, and hence also excludes patients who died in this period.